Table 1 -.

Procedure limb demographics, comorbidities and pre-operative medication regimens.

	CFA (n=8,378)	SFA (n=2,812)	P value
Age	67.1±10.5	66.3±12.1	0.0004
Male	5,599 (66.8)	1,969 (70.0)	0.002
Caucasian	6,885 (82.2)	2,324 (82.6)	0.575
Follow-Up Months	12.8±5.5	12.8±5.4	0.214
Comorbidities
BMI	27.2±6.2	28.2±6.1	<0.0001
Obese (BMI ≥30)	2,913 (34.8)	1,136 (40.4)	<0.0001
Smoking History	2,533 (42.2)	1,000 (35.6)	<0.0001
Diabetes	4,276 (51.0)	1,434 (51.0)	0.969
Coronary artery disease	2,663 (31.8)	776 (27.6)	<0.0001
Chronic obstructive pulmonary disorder	2,162 (25.8)	559 (19.9)	<0.0001
Congestive heart failure	175 (2.1)	55 (1.9)	0.667
End-stage renal disease	397 (4.7)	141 (5.0)	0.554
Non-ambulatory status	437 (5.2)	132 (4.7)	0.276
Indication			<0.0001
Claudication	2,047 (24.4)	571 (20.3)
Rest pain	2,056 (24.6)	660 (23.5)
Tissue loss	4,275 (51.0)	1,581 (56.2)
Prior inflow procedure	1,658 (19.8)	350 (12.5)	<0.0001
Prior ipsilateral infrainguinal endovascular intervention	2,302 (27.5)	688 (24.5)	0.002
Medications
Aspirin	6,183 (73.8)	2,002 (71.2)	0.007
P2Y12 inhibitor	2,878 (34.4)	759 (27.0)	<0.0001
Dual anti-platelet	2,167 (25.9)	579 (20.6)	<0.0001
Oral anticoagulation	2,946 (35.2)	1,057 (37.6)	0.020
Statin-use	2,108 (25.2)	854 (30.4)	<0.0001
Values reported as mean ± standard deviation; or no. (%).